Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Systematic Review Article

The Effect of Ginger (Zingiber officinale) on Improving Blood Lipids and Body Weight; A Systematic Review and Multivariate Meta-analysis of Clinical Trials

Author(s): Mohammad Asghari-Jafarabadi and Leila Khalili*

Volume 28, Issue 35, 2022

Published on: 06 October, 2022

Page: [2920 - 2943] Pages: 24

DOI: 10.2174/1381612828666220926093847

Price: $65

Abstract

Background: Beneficial effects of ginger consumption on metabolic biomarkers has been reported previously. The current research aimed to investigate the effects of ginger supplementation on lipid profile and body weight using a meta-analysis of randomized, controlled trials.

Methods: Online databases PubMed, Embase, Web of Science, and Science Direct were searched until December 2021 to identify eligible articles. Twenty-six trials were included.

Results: The results showed that ginger consumption could significantly improve lipid profile including total triglyceride (-12.54 (-20.01 to -5.08)), cholesterol (-6.53 (-10.76 to -2.31)), LDL (-5.14 (-8.79 to -1.50)), and HDL (1.13 (0.35 to 1.91)). Moreover, ginger supplementation could significantly decrease body mass index (BMI) (-0.49 (-0.79 to -0.18)). However, the small number of sample studies that investigated reductions in body weight (-0.52 (-1.48 to 0.43)) were not statistically significant. Sub-group analysis of treatment dose and duration showed that in most of the analyzed lipid profiles, both ≤1500 and >1500 mg/d for both of ≤8 and >8 weeks could be effective; however, in the case of weight control dose of >1500 mg/d for more than 8 weeks was more effective. Besides, the results of multivariate meta-analysis revealed the effect of the intervention on all lipid profiles simultaneously.

Conclusion: The present meta-analysis and review revealed that ginger supplementation can improve lipid profile and body weight if used at the appropriate dose and duration. More studies are needed to fully evaluate the effect of ginger supplements' different doses and duration on lipid profile and BMI.

Keywords: Meta-analysis, ginger, Zingiber officinale, blood lipids, BMI, lipid profile, body weight.

« Previous
[1]
Ahmed SM, Clasen ME, Donnelly JE. Management of dyslipidemia in adults. Am Fam Physician 1998; 57(9): 2192-2204, 2207-2208.
[PMID: 9606309]
[2]
Lordan S, Ross RP, Stanton C. Marine bioactives as functional food ingredients: Potential to reduce the incidence of chronic diseases. Mar Drugs 2011; 9(6): 1056-100.
[http://dx.doi.org/10.3390/md9061056] [PMID: 21747748]
[3]
Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115(5): e69-e171.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.179918] [PMID: 17194875]
[4]
McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case-control study. Lancet 2008; 372(9634): 224-33.
[http://dx.doi.org/10.1016/S0140-6736(08)61076-4] [PMID: 18640459]
[5]
Care D. Standards of medical care in diabetes 2019. Diabetes Care 2019; 42 (Suppl. 1): S124-38.
[http://dx.doi.org/10.2337/dc19-S011] [PMID: 30559237]
[6]
Goff DC Jr, Bertoni AG, Kramer H, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, ethnicity, and coronary artery calcium. Circulation 2006; 113(5): 647-56.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.552737] [PMID: 16461837]
[7]
Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: Systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3•0 million participants. Lancet 2011; 377(9765): 578-86.
[http://dx.doi.org/10.1016/S0140-6736(10)62038-7] [PMID: 21295847]
[8]
Khattab HA, Al-Amoudi NS, Al-Faleh A. Effect of ginger, curcumin and their mixture on blood glucose and lipids in diabetic rats. Life Sci J 2013; 10(4): 428-42.
[9]
Hassanalilou T, Payahoo L, Shahabi P, et al. The protective effects of Morus nigra L. leaves on the kidney function tests and histological structures in streptozotocin-induced diabetic rats. Biomed Res 2017; 28(14) Available from: https://www.alliedacademies.org/abstract/the-protective-effects-of-morus-nigra-l-leaves-on-thekidney- function-tests-and-histological-structures-in-streptozotocininduced- d-7938.html
[10]
Payahoo L, Khajebishak Y, Alivand MR, et al. Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial. Appetite 2019; 141: 104301.
[http://dx.doi.org/10.1016/j.appet.2019.05.032] [PMID: 31132422]
[11]
Kang YJ, Wang HW, Cheon SY, Lee HJ, Hwang KM, Yoon HS. Associations of obesity and dyslipidemia with intake of sodium, fat, and sugar among Koreans: A qualitative systematic review. Clin Nutr Res 2016; 5(4): 290-304.
[http://dx.doi.org/10.7762/cnr.2016.5.4.290] [PMID: 27812518]
[12]
Blake GH, Triplett L. Management of hypercholesterolemia. Am Fam Hys 1995; 51(5): 1157-66.
[13]
Association AD. Standards of medical care in diabetes. Diabetes Care 2010; 33 (Suppl. 1): S11-61.
[http://dx.doi.org/10.2337/dc10-S011] [PMID: 20042772]
[14]
Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63(25) (25 Part B): 2960-84.
[http://dx.doi.org/10.1016/j.jacc.2013.11.003] [PMID: 24239922]
[15]
Andallu B, Radhika B, Suryakantham V. Effect of aswagandha, ginger and mulberry on hyperglycemia and hyperlipidemia. Plant Foods Hum Nutr 2003; 58(3): 1-7.
[http://dx.doi.org/10.1023/B:QUAL.0000040352.23559.04]
[16]
Lantz RC, Chen GJ, Sarihan M, Sólyom AM, Jolad SD, Timmermann BN. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 2007; 14(2-3): 123-8.
[http://dx.doi.org/10.1016/j.phymed.2006.03.003] [PMID: 16709450]
[17]
Singletary K, Ginger SK. Nutr Today 2010; 45(4): 171-83.
[http://dx.doi.org/10.1097/NT.0b013e3181ed3543]
[18]
Grant KL, Lutz RB. Ginger. Am J Health Syst Pharm 2000; 57(10): 945-7.
[http://dx.doi.org/10.1093/ajhp/57.10.945] [PMID: 10832493]
[19]
Haniadka R, Saldanha E, Sunita V, Palatty PL, Fayad R, Baliga MS. A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe). Food Funct 2013; 4(6): 845-55.
[http://dx.doi.org/10.1039/c3fo30337c] [PMID: 23612703]
[20]
Panahi Y, Saadat A, Sahebkar A, Hashemian F, Taghikhani M, Abolhasani E. Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: A pilot, randomized, open-label clinical trial. Integr Cancer Ther 2012; 11(3): 204-11.
[http://dx.doi.org/10.1177/1534735411433201] [PMID: 22313739]
[21]
Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol 2008; 46(2): 409-20.
[http://dx.doi.org/10.1016/j.fct.2007.09.085] [PMID: 17950516]
[22]
Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 2006; 96(4): 660-6.
[http://dx.doi.org/10.1079/BJN20061849] [PMID: 17010224]
[23]
Nicoll R, Henein MY. Ginger (Zingiber officinale Roscoe): A hot remedy for cardiovascular disease? Int J Cardiol 2009; 131(3): 408-9.
[http://dx.doi.org/10.1016/j.ijcard.2007.07.107] [PMID: 18037515]
[24]
Prasad S, Kumar S, Vajpeyee S, Bhavsar V. To establish the effect of ginger-juice Zingiber officinale (zingiberaceae) on important parameters of lipid profile. Int J Pharm Sci Res 2012; 3(4): 352-6.
[25]
Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J 2008; 29(9): 1280-4.
[PMID: 18813412]
[26]
Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 2014; 65(4): 515-20.
[http://dx.doi.org/10.3109/09637486.2014.880671] [PMID: 24490949]
[27]
Mahluji S, Attari VE, Mobasseri M, Payahoo L, Ostadrahimi A, Golzari SEJ. Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. Int J Food Sci Nutr 2013; 64(6): 682-6.
[http://dx.doi.org/10.3109/09637486.2013.775223] [PMID: 23496212]
[28]
Pourmasoumi M, Hadi A, Rafie N, Najafgholizadeh A, Mohammadi H, Rouhani MH. The effect of ginger supplementation on lipid profile: A systematic review and meta-analysis of clinical trials. Phytomedicine 2018; 43: 28-36.
[http://dx.doi.org/10.1016/j.phymed.2018.03.043] [PMID: 29747751]
[29]
Maharlouei N, Tabrizi R, Lankarani KB, et al. The effects of ginger intake on weight loss and metabolic profiles among overweight and obese subjects: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2019; 59(11): 1753-66.
[http://dx.doi.org/10.1080/10408398.2018.1427044] [PMID: 29393665]
[30]
Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343(oct18 2): d5928.
[http://dx.doi.org/10.1136/bmj.d5928] [PMID: 22008217]
[31]
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 2009; 62(10): e1-e34.
[http://dx.doi.org/10.1016/j.jclinepi.2009.06.006] [PMID: 19631507]
[32]
Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Stat Med 1996; 15(6): 619-29.
[http://dx.doi.org/10.1002/(SICI)1097-0258(19960330)15:6<619:AID-SIM188>3.0.CO;2-A] [PMID: 8731004]
[33]
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-58.
[http://dx.doi.org/10.1002/sim.1186] [PMID: 12111919]
[34]
Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56(2): 455-63.
[http://dx.doi.org/10.1111/j.0006-341X.2000.00455.x] [PMID: 10877304]
[35]
White IR. Multivariate random-effects meta-analysis. Stata J 2009; 9(1): 40-56.
[http://dx.doi.org/10.1177/1536867X0900900103]
[36]
Carvalho GCN, Lira-Neto JCG. Araújo MFMd, Freitas RWJFd, Zanetti ML, Damasceno MMC. Effectiveness of ginger in reducing metabolic levels in people with diabetes: A randomized clinical trial. Rev Lat Am Enfermagem 2020; 28: e3369.
[37]
Carvalho GCN, Lira Neto JCG, Nunes LCC, Alencar AMPG, Marques RLL, Damasceno MMC. Effectiveness of ginger in the treatment of type 2 diabetes mellitus: A pilot study of the randomized clinical trial type. Aquichan 2021; 21(1): e2115.
[http://dx.doi.org/10.5294/aqui.2021.21.1.5]
[38]
Atashak S, Peeri M, Jafari A, Azarbayjani MA. Effects of ginger supplementation and resistance training on lipid profiles and body composition in obese men. J Med Plants Res 2011; 5(16): 3827-32.
[39]
Gholinezhad H, Bazyar H, Rashidi H, Salehi P, Haghighi-zadeh MH, Zare Javid A. Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial. J Herb Med 2020; 20: 100315.
[http://dx.doi.org/10.1016/j.hermed.2019.100315]
[40]
Ayaz A, Roshan VD. Effects of 6-weeks water-based intermittent exercise with and without Zingiber officinale on pro-inflammatory markers and blood lipids in overweight women with breast cancer. J Appl Pharm Sci 2012; 2(5): 218.
[http://dx.doi.org/10.7324/JAPS.2012.2547]
[41]
Rahimlou M, Yari Z, Rayyani E, et al. Effects of ginger supplementation on anthropometric, glycemic and metabolic parameters in subjects with metabolic syndrome: A randomized, double-blind, placebo-controlled study. J Diabetes Metab Disord 2019; 18(1): 119-25.
[http://dx.doi.org/10.1007/s40200-019-00397-z] [PMID: 31275882]
[42]
Babaahmadi-Rezaei H, Kheirollah A, Hesam S, et al. Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial. ARYA Atheroscler 2020; 16(4): 153-60.
[PMID: 33598035]
[43]
Rafie R, Hosseini SA, Hajiani E, Saki Malehi A, Mard SA. Effect of ginger powder supplementation in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Clin Exp Gastroenterol 2020; 13: 35-45.
[http://dx.doi.org/10.2147/CEG.S234698] [PMID: 32158249]
[44]
El Gayar MH, Aboromia MMM, Ibrahim NA, Abdel Hafiz MH. Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus. Obes Med 2019; 14: 100094.
[http://dx.doi.org/10.1016/j.obmed.2019.100094]
[45]
Navael Reza A, Fatemeh R, Mehrdad S, Mehdi P, Farzad J. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial 2008; 29(9): 1280-4.
[46]
Vahdatpoor H, Shakerian S, Alizadeh AA. FatemiTabatabaei SR. The combined effect of aerobic activity and ginger supplementation on blood glucose and lipid profile in overweight girls. Iranian Journal of Diabetes and Obesity 2019; 11(1): 1-8.
[47]
Makhdoomi Arzati M, Mohammadzadeh Honarvar N, Saedisomeolia A, et al. The effects of ginger on fasting blood sugar, hemoglobin A1c, and lipid profiles in patients with type 2 diabetes. Int J Endocrinol Metab 2017; 15(4): e57927.
[http://dx.doi.org/10.5812/ijem.57927] [PMID: 29344037]
[48]
Park SH, Jung SJ, Choi EK, et al. The effects of steamed ginger ethanolic extract on weight and body fat loss: A randomized, double-blind, placebo-controlled clinical trial. Food Sci Biotechnol 2020; 29(2): 265-73.
[http://dx.doi.org/10.1007/s10068-019-00649-x] [PMID: 32064135]
[49]
Tabibi H, Imani H, Atabak S, Najafi I, Hedayati M, Rahmani L. Effects of ginger on serum lipids and lipoproteins in peritoneal dialysis patients: A randomized controlled trial. Perit Dial Int 2016; 36(2): 140-5.
[http://dx.doi.org/10.3747/pdi.2015.00006] [PMID: 26475844]
[50]
Ebrahimzadeh Attari V, Mahluji S, Asghari Jafarabadi M, Ostadrahimi A. Effects of supplementation with ginger (Zingiber officinale roscoe) on serum glucose, lipid profile and oxidative stress in obese women: A randomized, placebo-controlled clinical trial. Pharm Sci 2015; 21(4): 184-91.
[http://dx.doi.org/10.15171/PS.2015.35]
[51]
Azimi P, Ghiasvand R, Feizi A, et al. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. Blood Press 2016; 25(3): 133-40.
[http://dx.doi.org/10.3109/08037051.2015.1111020] [PMID: 26758574]
[52]
Naseri H, Ayremlou P, Aghdashi MA, Seyyed Mardani SM, Zarrin R. The effect of ginger powder supplementation on lipid profile in rheumatoid arthritis patients. Razi J Med Sci 2017; 23(152): 18-28.
[53]
Talaei B, Mozaffari-Khosravi H, Bahreini S. The effect of Ginger on blood lipid and lipoproteins in patients with type 2 diabetes: A double-blind randomized clinical controlled trial. J Nutr Food Secur 2017; 2(1): 87-95.
[54]
Naderi Z, Mozaffari-Khosravi H, Dehghan A, Nadjarzadeh A, Huseini HF. Effect of ginger powder supplementation on nitric oxide and C-reactive protein in elderly knee osteoarthritis patients: A 12-week double-blind randomized placebo-controlled clinical trial. J Tradit Complement Med 2016; 6(3): 199-203.
[http://dx.doi.org/10.1016/j.jtcme.2014.12.007] [PMID: 27419081]
[55]
Farhadi M, Homaee H, Farzanegi Arkhazlou P. The effect of aerobic training and ginger extract on lipid profiles, body composition and liver enzymes in obese menopausal women. Iranian J Diab Obes 2020; 12(3): 156-63.
[http://dx.doi.org/10.18502/ijdo.v12i3.4458]
[56]
Nikkhah-Bodaghi M, Maleki I, Agah S, Hekmatdoost A. Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial. Complement Ther Med 2019; 43: 1-6.
[http://dx.doi.org/10.1016/j.ctim.2018.12.021] [PMID: 30935515]
[57]
Shidfar F, Rajab A, Rahideh T, Khandouzi N, Hosseini S, Shidfar S. The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. J Complement Integr Med 2015; 12(2): 165-70.
[http://dx.doi.org/10.1515/jcim-2014-0021] [PMID: 25719344]
[58]
Mozaffari-Khosravi H, Talaei B, Jalali BA, Najarzadeh A, Mozayan MR. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Complement Ther Med 2014; 22(1): 9-16.
[http://dx.doi.org/10.1016/j.ctim.2013.12.017] [PMID: 24559810]
[59]
Elgayar M, Mahdy M, Ibrahim N, Abdelhafiz M. Effects of ginger powder supplementation on glycemic status and lipid profile in patients with type 2 diabetes mellitus. QJM: Int J Med 2020; 113(Supplement_1): hcaa052.
[60]
Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 2000; 130(5): 1124-31.
[http://dx.doi.org/10.1093/jn/130.5.1124] [PMID: 10801908]
[61]
Parthasarathy VA, Chempakam B, Zachariah TJ. Chemistry of spices Cabi London 2008 Available from:.
[http://dx.doi.org/10.1079/9781845934057.0000]
[62]
Cardia G, Grisorio D, Impedovo G, Lillo A, Regina G. Plasma lipids as a risk factor in peripheral vascular disease. Angiology 1990; 41(1): 19-22.
[http://dx.doi.org/10.1177/000331979004100103] [PMID: 2305996]
[63]
Hymoor S, Al-Noory AS, Amreen A-N. Antihyperlipidemic effects of ginger extracts in alloxan-induced diabetes and propylthiouracil-induced hypothyroidism in (rats). Pharmacognosy Res 2013; 5(3): 157-61.
[http://dx.doi.org/10.4103/0974-8490.112419] [PMID: 23901210]
[64]
Ness GC, Zhao Z, Lopez D. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation. Arch Biochem Biophys 1996; 325(2): 242-8.
[http://dx.doi.org/10.1006/abbi.1996.0030] [PMID: 8561503]
[65]
Platel K, Srinivasan K. Influence of dietary spices and their active principles on pancreatic digestive enzymes in albino rats. Food 2000; 44(1): 42-6. 42::AID-FOOD42>3.0.CO;2-D
[http://dx.doi.org/10.1002/(SICI)1521-3803(20000101)44:1]
[66]
Ramakrishna Rao R, Platel K, Srinivasan K. In vitro influence of spices and spice-active principles on digestive enzymes of rat pancreas and small intestine. Food 2003; 47(6): 408-12.
[http://dx.doi.org/10.1002/food.200390091]
[67]
Liu N, Huo G, Zhang L, Zhang X. Effect of Zingiber officinaleRosc on lipid peroxidation in hyperlipidemia rats. Wei Sheng Yen Chiu 2003; 32(1): 22-3.
[PMID: 12731279]
[68]
Hashimoto K, Satoh K, Murata P, et al. Component of Zingiber officinale that improves the enhancement of small intestinal transport. Planta Med 2002; 68(10): 936-9.
[http://dx.doi.org/10.1055/s-2002-34928] [PMID: 12391562]
[69]
Srinivasan K, Sambaiah K. The effect of spices on cholesterol 7 alpha-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Int J Vitam Nutr Res 1991; 61(4): 364-9.
[70]
Shirdel Z, Mirbadalzadeh R, Madani H. Antidiabetic and antilipidemic effect of ginger in alloxan monohydrate diabetic rats in comparison with glibenclamide. Iran J Diabetes Lipid Disord 2009; 9(1): 7-15.
[71]
Gao H, Guan T, Li C, Zuo G, Yamahara J, Wang J, et al. Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: Modulation of the hepatic carbohydrate response element-binding protein-mediated pathway. Evidence-Based Compl Alter Med 2012; 2012.
[http://dx.doi.org/10.1155/2012/570948]
[72]
Brahma Naidu P, Uddandrao VVS, Ravindar Naik R, et al. Ameliorative potential of gingerol: Promising modulation of inflammatory factors and lipid marker enzymes expressions in HFD induced obesity in rats. Mol Cell Endocrinol 2016; 419: 139-47.
[http://dx.doi.org/10.1016/j.mce.2015.10.007] [PMID: 26493465]
[73]
Saravanan G, Ponmurugan P, Deepa MA, Senthilkumar B. Anti-obesity action of gingerol: Effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J Sci Food Agric 2014; 94(14): 2972-7.
[http://dx.doi.org/10.1002/jsfa.6642] [PMID: 24615565]
[74]
Zannis VI, Chroni A, Kypreos KE, et al. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer. Curr Opin Lipidol 2004; 15(2): 151-66.
[http://dx.doi.org/10.1097/00041433-200404000-00008] [PMID: 15017358]
[75]
Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56(5): 379-84.
[http://dx.doi.org/10.1016/S0952-3278(97)90587-1] [PMID: 9175175]
[76]
Mansour MS, Ni YM, Roberts AL, Kelleman M. RoyChoudhury A, St-Onge MP. Ginger consumption enhances the thermic effect of food and promotes feelings of satiety without affecting metabolic and hormonal parameters in overweight men: A pilot study. Metabolism 2012; 61(10): 1347-52.
[http://dx.doi.org/10.1016/j.metabol.2012.03.016] [PMID: 22538118]
[77]
Pulbutr P, Thunchomna K, Lawa K, Mangkhalat A, Saenubol P. Lipolytic effects of zingerone in adipocytes isolated from normal diet-fed rats and high fat diet-fed rats. Int J Pharmacol 2011; 7(5): 629-34.
[http://dx.doi.org/10.3923/ijp.2011.629.634]
[78]
Fujisawa F, Nadamoto T, Fushiki T. Effect of intake of ginger on peripheral body temperature. J Jap Soc Nutr Food Sci 2005; 58(1): 3-9.
[79]
Ahn EK, Oh JS. Inhibitory effect of galanolactone isolated from Zingiber officinale roscoe extract on adipogenesis in 3T3-L1 cells. J Korean Soc Appl Biol Chem 2012; 55(1): 63-8.
[http://dx.doi.org/10.1007/s13765-012-0011-6]
[80]
Shalaby M, Saifan H. Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats. J Intercult Ethnopharmacol 2014; 3(4): 144-9.
[http://dx.doi.org/10.5455/jice.20140818050741] [PMID: 26401364]
[81]
Iwasaki Y, Morita A, Iwasawa T, et al. A nonpungent component of steamed ginger-[10]-shogaol-Increases adrenaline secretion via the activation of TRPV1. Nutr Neurosci 2006; 9(3-4): 169-78.
[http://dx.doi.org/10.1080/110284150600955164] [PMID: 17176640]
[82]
Mahmoud RH, Elnour WA. Comparative evaluation of the efficacy of ginger and orlistat on obesity management, pancreatic lipase and liver peroxisomal catalase enzyme in male albino rats. Eur Rev Med Pharmacol Sci 2013; 17(1): 75-83.
[PMID: 23329526]
[83]
Macit MS, Sözlü S, Kocaadam B, Acar-Tek N. Evaluation of ginger (Zingiber officinale Roscoe) on energy metabolism and obesity: Systematic review and meta-analysis. Food Rev Int 2019; 35(7): 685-706.
[http://dx.doi.org/10.1080/87559129.2019.1608556]
[84]
Jafarnejad S, Keshavarz SA, Mahbubi S, et al. Effect of ginger (Zingiber officinale) on blood glucose and lipid concentrations in diabetic and hyperlipidemic subjects: A meta-analysis of randomized controlled trials. J Funct Foods 2017; 29: 127-34.
[http://dx.doi.org/10.1016/j.jff.2016.12.006]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy